{"member_organisations": "", "identification_number": "844250927798-90", "fields_of_interest": "Public Health", "head_office_address": "Schillerstr. 5", "full_time_equivalent_fte": "0,25", "person_with_legal_responsibility": "Frank Trautwein", "industry_forums": "", "grants": "", "country_code": "de", "inter_groups": "", "eu_initiatives": "health care, medical devices, medical device regulation, diagnosis, AI (Artificial intelligence), clinical studies, clinical trials", "level_of_interest": "European, national", "organisation_name": "Raylytic GmbH", "belgium_office_post_code": "", "number_of_persons_involved": "1", "person_in_charge_of_eu_relations": "Frank Trautwein", "section": "I - Professional consultancies/law firms/self-employed consultants", "lon": "12.3769422304411", "source": "", "subsection": "Professional consultancies", "belgium_office_phone": "", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "", "persons_accredited_for_access_to_european_parliament_premises": "", "registration_date": "20/07/2017", "estimate_of_costs_absolute_amount": "0", "website_address": "http://raylytic.com", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Leipzig", "membership": "VDI,  https://www.vdi.de/ \nAOSpine, https://aospine.aofoundation.org \nNASS, https://www.spine.org/ \nBioregio Stern, http://www.bioregio-stern.de/ \nbitkom, http://bitkom.org", "head_office_post_code": "04109", "position": "Managing Director", "financial_year_start_date": "", "head_office_country": "Germany", "number_of_ep_accredited_persons": "", "relevant_communication": "", "financial_year_end_date": "", "lat": "51.3371085", "estimate_of_costs_as_a_range": "", "overall_budget_turnover_absolute_amount": "0", "legal_status": "GmbH", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "Raylytic is an independent imaging core lab. We analyze medical devices for clinical approval and conduct post market clinical follow-up studies on behalf of industry, research and hospitals. Our aim is to provide meaningful insight in a medical devices' performance and clinical outcome. The data we generate is reviewed by notified bodies, and government organizations, such as the US-FDA. We develop and utilize technology based on AI and machine learning to automatically asses over 100 relevant parameters from medical images in typically large patient cohorts .", "belgium_office_city": "", "head_office_phone": "(+49)07117874162"}